News headlines about Alcentra Capital (NASDAQ:ABDC) have been trending somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alcentra Capital earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media coverage about the asset manager an impact score of 45.8813503383574 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Several equities research analysts have commented on the company. Rowe cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Raymond James Financial cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. ValuEngine upgraded Alcentra Capital from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. UBS Group cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $9.50 price objective on shares of Alcentra Capital in a research note on Friday, November 10th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $12.83.
Shares of Alcentra Capital (ABDC) opened at $8.40 on Wednesday. Alcentra Capital has a 12 month low of $7.00 and a 12 month high of $14.73. The stock has a market capitalization of $122.51, a P/E ratio of 17.50 and a beta of 0.62.
Alcentra Capital announced that its Board of Directors has initiated a share repurchase program on Monday, November 6th that authorizes the company to buyback $2.50 million in outstanding shares. This buyback authorization authorizes the asset manager to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 4th. Stockholders of record on Friday, December 29th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.90%. The ex-dividend date of this dividend was Thursday, December 28th. Alcentra Capital’s dividend payout ratio is currently 208.33%.
In related news, Director Paul J. Echausse sold 10,000 shares of the stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $7.45, for a total value of $74,500.00. Following the sale, the director now owns 58,946 shares in the company, valued at approximately $439,147.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Steven H. Reiff purchased 6,900 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was acquired at an average price of $7.23 per share, for a total transaction of $49,887.00. Following the purchase, the director now owns 35,246 shares in the company, valued at approximately $254,828.58. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 11,730 shares of company stock worth $83,956. Company insiders own 4.96% of the company’s stock.
WARNING: This piece was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/10/alcentra-capital-abdc-receives-media-impact-score-of-0-03.html.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
What are top analysts saying about Alcentra Capital? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Alcentra Capital and related companies.